OMEGA-3 Interventions in Alcohol Dependence and Related Outcomes: A Systematic Review and Propositions

Curr Neuropharmacol. 2020;18(5):456-462. doi: 10.2174/1570159X18666200128120729.

Abstract

Background: Pharmacological treatment for alcohol dependence has only three approved drugs: disulfiram, naltrexone and acamprosate. The effects of these drugs are, however, limited, presenting several side effects and a modestly higher efficacy compared to placebo. The administration of omega-3 might bring new perspectives to relapse prevention.

Methods: This systematic review aimed to analyze the available literature, compiling the studies that used omega-3 to prevent relapse in alcohol dependents.

Results: The databases used were PubMed and Web of Science. We identified 2,231 studies and only five articles addressed the administration of omega-3 and alcoholism. Preclinical studies evaluating the effects of PUFAs related to chronic alcohol administration showed improvements in behavioral, cellular and molecular levels. The clinical trial yielded inconclusive results.

Conclusion: Despite the reduced number of studies, omega-3 interventions seem to be promising for controlling issues related to alcohol dependence.

Keywords: PUFAs; craving; ethanol; omega-3; relapse; treatment..

Publication types

  • Systematic Review

MeSH terms

  • Alcoholism / drug therapy*
  • Animals
  • Behavior, Animal / drug effects
  • Clinical Trials as Topic
  • Fatty Acids, Omega-3 / administration & dosage
  • Fatty Acids, Omega-3 / therapeutic use*
  • Humans
  • Secondary Prevention / methods
  • Treatment Outcome

Substances

  • Fatty Acids, Omega-3